A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.
Hanhee Jo, Sarah Munoz, Aneesh Dalvi, Wenqi Yang, Elizabeth Morozova, Stacey M. Glasgow
This study identifies NUAK2 as a fetal oncogene in glioblastoma, showing its role in promoting cell proliferation and migration, and demonstrates that its inhibition can suppress tumor growth.
EMBO Molecular Medicine · Aug 6, 2025Peer-reviewedCell Biology